Everest Organics files first US DMF

04 Sep 2019

Everest Organics has submitted the first US DMF for Esomeprazole Magnesium API.

Ever since the successful USFDA approval received for its manufacturing facility, the company has placed a separate focus to strengthen its presence in regulatory markets. With the first filing of US-DMF for Esomeprazole Magnesium, the company focuses to increase presence in the US market for substantial revenue generation.

Everest Organics is a fast growing API and Bulk drug manufacturing company with world class facility and it is committed to manufacturing excellent quality products and customer service.

Related Everest Organics Ltd. Links:

Everest Organics Share Price

171.00 -3.00 (-1.72%) Dec 10, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 427.50
Lupin 752.15
Dr. Reddys Lab 2896.95
Piramal Enterprises 1609.85
Cadila Healthcare 260.95
View more..
Sensex vs Everest Organics
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463